Simplex Trading’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $745K | Sell |
22,900
-199,100
| -90% | -$6.4M | ﹤0.01% | 2810 |
|
|
2025
Q4 | $7.81M | Buy |
222,000
+92,300
| +71% | +$3.27M | ﹤0.01% | 1006 |
|
|
2025
Q3 | $3.41M | Sell |
129,700
-41,400
| -24% | -$1.24M | ﹤0.01% | 1815 |
|
|
2025
Q2 | $4.53M | Buy |
171,100
+11,000
| +7% | +$290K | ﹤0.01% | 1430 |
|
|
2025
Q1 | $3.87M | Sell |
160,100
-6,400
| -4% | -$202K | ﹤0.01% | 1479 |
|
|
2024
Q4 | $6.7M | Buy |
166,500
+14,200
| +9% | +$810K | ﹤0.01% | 1271 |
|
|
2024
Q3 | $9.64M | Sell |
152,300
-99,100
| -39% | -$5.81M | 0.01% | 1060 |
|
|
2024
Q2 | $13.3M | Sell |
251,400
-143,900
| -36% | -$9.43M | 0.01% | 830 |
|
|
2024
Q1 | $32.4M | Buy |
395,300
+324,700
| +460% | +$14.4M | 0.02% | 483 |
|
|
2023
Q4 | $1.31M | Buy |
70,600
+34,400
| +95% | +$450K | ﹤0.01% | 2755 |
|
|
2023
Q3 | $400K | Sell |
36,200
-153,400
| -81% | -$2.19M | ﹤0.01% | 3637 |
|
|
2023
Q2 | $3.07M | Buy |
189,600
+136,400
| +256% | +$2.86M | ﹤0.01% | 1643 |
|
|
2023
Q1 | $885K | Sell |
53,200
-35,600
| -40% | -$368K | ﹤0.01% | 2699 |
|
|
2022
Q4 | $834K | Buy |
88,800
+87,100
| +5,124% | +$389K | ﹤0.01% | 2651 |
|
|
2022
Q3 | $4K | Buy |
+1,700
| New | +$5.57K | ﹤0.01% | 8980 |
|
|
2022
Q2 | – | Sell |
-17,100
| Closed | -$51K | – | 11194 |
|
|
2022
Q1 | $51K | Sell |
17,100
-14,500
| -46% | -$52K | ﹤0.01% | 7109 |
|
|
2021
Q4 | $145K | Sell |
31,600
-8,900
| -22% | -$49.9K | ﹤0.01% | 5656 |
|
|
2021
Q3 | $256K | Hold |
40,500
| – | – | ﹤0.01% | 5187 |
|
|
2021
Q2 | $242K | Buy |
40,500
+39,929
| +6,993% | +$237K | ﹤0.01% | 5369 |
|
|
2021
Q1 | $361K | Sell |
571
-334
| -37% | -$2.35K | ﹤0.01% | 3878 |
|
|
2020
Q4 | $509K | Sell |
905
-7
| -0.8% | -$42 | ﹤0.01% | 3399 |
|
|
2020
Q3 | $530K | Sell |
912
-84
| -8% | -$578 | ﹤0.01% | 2932 |
|
|
2020
Q2 | $718K | Buy |
996
+112
| +13% | +$744 | ﹤0.01% | 2463 |
|
|
2020
Q1 | $413K | Buy |
884
+417
| +89% | +$2.56K | ﹤0.01% | 2799 |
|
|
2019
Q4 | $374K | Buy |
467
+166
| +55% | +$1.21K | ﹤0.01% | 3046 |
|
|
2019
Q3 | $207K | Sell |
301
-209
| -41% | -$1.55K | ﹤0.01% | 3534 |
|
|
2019
Q2 | $423K | Sell |
510
-95
| -16% | -$812 | ﹤0.01% | 2724 |
|
|
2019
Q1 | $601K | Buy |
605
+218
| +56% | +$1.82K | ﹤0.01% | 2475 |
|
|
2018
Q4 | $296K | Sell |
387
-937
| -71% | -$11.2K | ﹤0.01% | 2739 |
|
|
2018
Q3 | $2.31M | Buy |
1,324
+1,066
| +413% | +$12.7K | 0.01% | 1131 |
|
|
2018
Q2 | $244K | Buy |
258
+240
| +1,333% | +$1.6K | ﹤0.01% | 3251 |
|
|
2018
Q1 | $4K | Buy |
+18
| New | +$100 | ﹤0.01% | 4846 |
|
Other funds holding VKTX
VCM
VPM
Simplex Trading's VKTX Position: Q4 2025 in Review
Simplex Trading sold out of Viking Therapeutics (VKTX) in Q4 2025, closing a stake of 33,354 shares — an estimated $1.18M sold.
Simplex Trading first reported a position in VKTX in Q1 2018 and held it in 20 quarters. The position peaked at $4.82M in Q1 2023. 424 funds tracked by Wall St. Rank hold VKTX as of Q4 2025.
- Simplex Trading reported no remaining Viking Therapeutics position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 33,354 Viking Therapeutics shares in Q4 2025, an estimated $1.18M.
- Simplex Trading first reported a position in Viking Therapeutics in Q1 2018 and held it in 20 quarters.
- Simplex Trading's Viking Therapeutics position peaked at $4.82M in Q1 2023.
- 424 funds tracked by Wall St. Rank held Viking Therapeutics as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.